According to International diabetes federation, in 2018, there are around 271.8 Million of people living with diabetes in the world. Diabetes people all over the world use glucose meter, test strips and lancing device to measure the blood glucose level. There are many diabetes patients especially insulin dependent that has severe hypoglycemic and hyperglycemic index level. They use 3-4 or even more than that strips on the daily basis to monitor the blood glucose level. As monitoring blood glucose is an essential part of diabetes management. Moreover, SMBG device are convenient to use at any point of time before breakfast, before meal, after meal and before –after exercise. According to Renub Research the Global Blood Glucose Device Market is expected to surpass US$ 25 Billion mark by the end of the year 2025.
Access full Research:
The SMBG market is growing with rapid pace due to numerous key factors like rising global diabetes population (type 1 diabetes and type 2 diabetes), increasing insulin dependent diabetes population, increasing obese population, rise in ageing population, rising awareness regarding diabetes and technological advancement of SMBG device that makes convenience for patient to easily measure blood glucose level. According to Renub Research Analysis, rising penetration of SMBG user among developed and developing countries will further boost the global blood glucose device market in forecast year.
“Blood Glucose Device Market, Users Global Forecast, SMBG Components (Test Strips, Lancet, Meter) of 17 Countries (USA, Europe, Asia & Pacific, Middle East & Africa) & Companies (Roche, LifeScan Inc. HealthCare, Abbott)” analyzes the worldwide market for, blood glucose test strips market, blood glucose lancet market and blood glucose meter market. This is the 5th publication on Blood Glucose Device Market by Renub Research.
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.